High Strength Product Designed to Make People Feel Their Best.

Charlotte, North Carolina--(Newsfile Corp. - October 13, 2022) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA), one of the nation's leading, highly trusted and widely recognized CBD companies, announced their latest initiative that involves a new line up of products delivering higher concentrations of CBD for daily use.

According to category insights, people need to take enough CBD so they can feel better and at a price they can afford every day. Through its rigorous research program, cbdMD has made a significant investment to better understand exactly how CBD interacts with the body. cbdMD is leading the industry with an expanded line of products including softgels, tinctures, tablets and gummies to address the needs of a wider audience. This new, innovative product lineup has an optimized blend of cannabinoids designed to maximize efficacy and help our customers feel their best. cbdMD has taken a disruptive approach to formulate products at industry leading concentrations to make feeling your best affordable.

"After months of planning, we are excited to showcase our new product lineup. Our commitment to using science to provide consumers with affordable solutions makes our high-strength product offering the most compelling in the industry," said Kevin MacDermott, President of cbdMD. "As CBD gains more widespread acceptance as a viable wellness alternative this initiative will increase customer engagement and take market share from competing brands, effectively disrupting the growing CBD marketplace."

About cbdMD, Inc.

cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free¹ CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD's full lineup of products are currently available to ship across the USA² and to many countries worldwide³.

To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, check our LinkedIn page, follow cbdMD on Instagram and Facebook, or visit one of the thousands of retail outlets that carry cbdMD products.

Forward-Looking Statements

This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified using words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.'' These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict. You are urged to carefully review and consider any cautionary statements, including but not limited to expectations on cost reductions, and other disclosures, including the statements made under the heading "Risk Factors" in cbdMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended September 30, 2021 as filed with the Securities and Exchange Commission (the "SEC") on December 17, 2021 and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are generally outside the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.

¹ THC-free is defined as below the level of detection using validated scientific analytical tools.
²Unless otherwise limited by known state or local jurisdiction.
³Shipment outside of the United States is limited by the laws of the specific jurisdiction.

Contacts:

cbdMD, Inc.

Ronan Kennedy, CFO
+1 (704) 445-3064
IR@cbdmd.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/140435